Use of recombinant factor VIIa in infants with severe coagulopathy

Journal of Perinatology

Volumn 24, Issue 5, 2004, Pages 310-311

  Fontaine, Magali J ^a   Lazarchick, John ^b   Taylor, Sarah ^b   Annibale, David ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; BLOOD CLOTTING DISORDER; CASE REPORT; DISEASE SEVERITY; DRUG CLEARANCE; DRUG COST; DRUG MECHANISM; DRUG RESPONSE; DRUG USE; FEMALE; HEART INFARCTION; HUMAN; LAPAROTOMY; LIVER CIRRHOSIS; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PARACENTESIS; PLASMA TRANSFUSION; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

BLOOD COAGULATION DISORDERS; FACTOR VII; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; RECOMBINANT PROTEINS;

EID: 2542493016     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211086     Document Type: Review

References (12)

1. Hedner U. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Hemost 2000;26(4);363-72.
2. Negrier C, Hay CRM. The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa. Semin Thromb Hemost 2000;26(4):407-12.
3. Shapiro AD. Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors. Semin Thromb Hemost 2000;26(4);413-9.
4. Van't Veer C, Mann KG. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost 2000;26(4):367-72.
5. Schulman S. Continous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectiveness. Semin Thromb Hemost 2000;(4):421-4.
6. Lucia JF, et al. Successful outcome of a cirrhotic patients with postoperative haematuria treated with a single high dose of recombinant factor VIIa. Haemophilia 2001;7:600-2.
7. Greisen G, Andreasen RB. Recombinant factor VIIa in preterm neonates with prolonged prothrombin time. Blood Coagulation Fibrinol 2003;14(1):117-20.
8. Tobias JD, Groeper K, Berkenbosch JW. Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 2003;96(1):12-6.
9. Lisman T, De Groot G. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003;1(6):1138.
10. Aledort LM, rFVIIa-its thrombogenicity. Thromb Haemost 2000;84:522-3.
11. Chuansumrit A, Nuntnarumit P, Okasharoen C, Teeratkul S, Suwansingh S, Supapannachart S. The use of recombinant activated factor VIIa to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 2002;107(1):169-71.
12. Bernstein D. Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis. Semin Thromb Hemost 2000;26(4):437-8.